RESMED INC
NYSE: RMD. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:d9f24089-580a-46b4-ba58-2bb1bb002787
- SEC CIK
- 0000943819
- Website
- www.resmed.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Oct 2, 2025
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Michael FarrellChairman and Chief Executive Officer
- Chair
- Michael FarrellLead independent: Ross Taylor
- Independent
- Not published9 directors published
- Published claims
- 485 distinct sources
- Evidence records
- 170 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 17 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Carol Burt seat on RESMED INC, effective 2025-10-02.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Financial Officer | Brett Sandercock | Not captured | unknown | Source reportedE14 |
| Chief Product Officer | Justin Leong | Not captured | unknown | Source reportedE14 |
| Chairman and Chief Executive Officer | Michael Farrell | Not captured | unknown | Source reportedE14 |
| Global General Counsel and Secretary | Michael Rider | Not captured | unknown | Source reportedE14 |
Board of directors
Evidence9 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Carol Burt | Independence not published | 2025 | AuditAudit; Compliance, Privacy and Quality; Nominating and Governance · ChairCompliance, Privacy and QualityNominating and Governance, chair | Source reportedE4 |
| Christopher DelOrefice | Independence not published | 2025 | Audit, chairAudit · Chair | Source reportedE5 |
| Desney Tan | Independence not published | 2025 | Compensation and Leadership DevelopmentCompensation and Leadership Development; Nominating and GovernanceNominating and Governance | Source reportedE6 |
| Harjit Gill | Independence not published | 2025 | AuditAudit; Compensation and Leadership Development; Compliance, Privacy and QualityCompensation and Leadership DevelopmentCompliance, Privacy and Quality | Source reportedE7 |
| Jerry D. Witte | Independence not published | 2025 | AuditAudit; Compensation and Leadership Development; Nominating and GovernanceCompensation and Leadership DevelopmentNominating and Governance | Source reportedE8 |
| John Hernandez | Independence not published | 2025 | AuditAudit; Compliance, Privacy and QualityCompliance, Privacy and Quality | Source reportedE9 |
| Karen Drexler | Independence not published | 2025 | Compensation and Leadership Development, chairCompensation and Leadership Development · Chair; Compliance, Privacy and Quality; Nominating and GovernanceCompliance, Privacy and QualityNominating and Governance | Source reportedE10 |
| Nicole Mowad-Nassar | Independence not published | 2025 | Compliance, Privacy and Quality | Source reportedE11 |
| Ross Taylor | Independence not publishedLead Independent | 2025 | Audit | Source reportedE13 |
| Michael Farrell | Independence not publishedChair | Not published | None published | Source reportedE3 |
| Peter Farrell | Independence not published | Not published | None published | Source reportedE12 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Christopher DelOrefice | Christopher DelOrefice, Carol Burt, Harjit Gill, Jerry D. Witte, John Hernandez, Ross Taylor | Not described in the published record |
| Audit · Chair | Not published | Christopher DelOrefice | Not described in the published record |
| Audit; Compensation and Leadership Development; Compliance, Privacy and Quality | Not published | Harjit Gill | privacy, regulatory |
| Audit; Compensation and Leadership Development; Nominating and Governance | Not published | Jerry D. Witte | Not described in the published record |
| Audit; Compliance, Privacy and Quality | Not published | John Hernandez | privacy, regulatory |
| Audit; Compliance, Privacy and Quality; Nominating and Governance · Chair | Not published | Carol Burt | privacy, regulatory |
| Compensation and Leadership Development | Karen Drexler | Karen Drexler, Desney Tan, Harjit Gill, Jerry D. Witte | Not described in the published record |
| Compensation and Leadership Development · Chair; Compliance, Privacy and Quality; Nominating and Governance | Not published | Karen Drexler | privacy, regulatory |
| Compensation and Leadership Development; Nominating and Governance | Not published | Desney Tan | Not described in the published record |
| Compliance, Privacy and Quality | Not published | Carol Burt, Harjit Gill, John Hernandez, Karen Drexler, Nicole Mowad-Nassar | privacy, regulatory |
| Nominating and Governance | Carol Burt | Carol Burt, Desney Tan, Jerry D. Witte, Karen Drexler | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
Evidence| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | RSMDF | current | Jul 26, 2017 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Brett SandercockChief Financial Officercompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:20
- Justin LeongChief Product Officercompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:21
- Michael FarrellChairman and Chief Executive Officercompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:22, company:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:9
- Michael RiderGlobal General Counsel and Secretarycompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:23
- Carol BurtDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:10
- Christopher DelOreficeDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:11
- Desney TanDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:12
- Harjit GillDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:13
- Jerry D. WitteDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:14
- John HernandezDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:15
- Karen DrexlerDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:16
- Nicole Mowad-NassarDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:17
- Ross TaylorLead Independent Directorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:19
- Peter FarrellDirectorcompany:d9f24089-580a-46b4-ba58-2bb1bb002787:leadership_role:18
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 17 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 7 Claims.
- E2RESMED INC Form 10-K (filed 2026-08-13). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec filing. Published Oct 2, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E4sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E5sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E6sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E7sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E8sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E9sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E10sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E11sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E12sec filing. Published Oct 2, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E13sec filing. Published Oct 2, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E14sec def 14a. Published Oct 2, 2025. Retrieved Sep 14, 2026. Cited by 4 Claims.
- E15board_seats. board seats. Cited by 7 Claims.
- E16board_seats. board seats. Cited by 16 Claims.
- E17Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Carol Burt seat on RESMED INC, effective 2025-10-02.
- Christopher DelOrefice seat on RESMED INC, effective 2025-10-02.
- Desney Tan seat on RESMED INC, effective 2025-10-02.
- Harjit Gill seat on RESMED INC, effective 2025-10-02.
- Jerry D. Witte seat on RESMED INC, effective 2025-10-02.
- John Hernandez seat on RESMED INC, effective 2025-10-02.
- Karen Drexler seat on RESMED INC, effective 2025-10-02.
- Nicole Mowad-Nassar seat on RESMED INC, effective 2025-10-02.
- Ross Taylor seat on RESMED INC, effective 2025-10-02.
- Ross Taylor lead independent director of RESMED INC, effective 2025-10-02.
- Audit · Chair committee of RESMED INC, effective 2025-10-02.
- Christopher DelOrefice member of Audit · Chair, effective 2025-10-02.
- Audit; Compensation and Leadership Development; Compliance, Privacy and Quality committee of RESMED INC, effective 2025-10-02.
- Harjit Gill member of Audit; Compensation and Leadership Development; Compliance, Privacy and Quality, effective 2025-10-02.
- Audit; Compensation and Leadership Development; Nominating and Governance committee of RESMED INC, effective 2025-10-02.
- Jerry D. Witte member of Audit; Compensation and Leadership Development; Nominating and Governance, effective 2025-10-02.
- Audit; Compliance, Privacy and Quality committee of RESMED INC, effective 2025-10-02.
- John Hernandez member of Audit; Compliance, Privacy and Quality, effective 2025-10-02.
- Audit; Compliance, Privacy and Quality; Nominating and Governance · Chair committee of RESMED INC, effective 2025-10-02.
- Carol Burt member of Audit; Compliance, Privacy and Quality; Nominating and Governance · Chair, effective 2025-10-02.
- Compensation and Leadership Development · Chair; Compliance, Privacy and Quality; Nominating and Governance committee of RESMED INC, effective 2025-10-02.
- Karen Drexler member of Compensation and Leadership Development · Chair; Compliance, Privacy and Quality; Nominating and Governance, effective 2025-10-02.
- Compensation and Leadership Development; Nominating and Governance committee of RESMED INC, effective 2025-10-02.
- Desney Tan member of Compensation and Leadership Development; Nominating and Governance, effective 2025-10-02.

